When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

In March, short sellers collectively increased their negative bets on the broader healthcare industry, as indicated by a rise ...

Jabil benefits from minimal tariff impact due to its B2B model, often passing costs to end-product companies. Check out why I ...

If you’re an income-focused investor, there is room for you on Barchart’s Top 100 Stocks to Buy bandwagon. The 100 stocks ...

Some of Wall Street's most-prominent asset managers were scooping up shares of time-tested businesses before the stock market ...

Small cap stocks, or those companies with market capitalizations between $300 million and $2 billion, are a vital component ...

On April 17, Joyce Chang, JPMorgan chair of global research, appeared on CNBC’s ‘Closing Bell Overtime’ to talk about ...

British stocks ended lower on Wednesday, dragged by heavyweight pharmaceutical stocks, while markets remained focused on ...

UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Futures on Wall Street continue to tread lower after Monday's steep sell-off, which saw the Dow Jones fall as much as 1,300 ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apellis Pharmaceuticals (APLS – Research Report), Skye ...